Treatment of Highly Drug-Resistant Pulmonary Tuberculosis | Zendy

Francesca Conradie | Zendy; Andreas H. Diacon | Zendy; Nosipho Ngubane | Zendy; Pauline Howell | Zendy; Daniel E. Everitt | Zendy; Angela M. Crook | Zendy; Carl M. Mendel | Zendy; Erica Egizi | Zendy; Joanna Moreira | Zendy; Juliano Timm | Zendy; Timothy D. McHugh | Zendy; Genevieve H. Wills | Zendy; Matthew Bates | Zendy; Robert Hunt | Zendy; Christo van Niekerk | Zendy; Mengchun Li | Zendy; Morounfolu Olugbosi | Zendy; Melvin Spigelman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

Author(s) -

Francesca Conradie,

Andreas H. Diacon,

Nosipho Ngubane,

Pauline Howell,

Daniel E. Everitt,

Angela M. Crook,

Carl M. Mendel,

Erica Egizi,

Joanna Moreira,

Juliano Timm,

Timothy D. McHugh,

Genevieve H. Wills,

Matthew Bates,

Robert Hunt,

Christo van Niekerk,

Mengchun Li,

Morounfolu Olugbosi,

Melvin Spigelman

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1901814

Subject(s) - tuberculosis , drug , medicine , pulmonary tuberculosis , drug resistance , intensive care medicine , extensively drug resistant tuberculosis , drug resistant tuberculosis , pharmacology , mycobacterium tuberculosis , microbiology and biotechnology , pathology , biology

Patients with highly drug-resistant forms of tuberculosis have limited treatment options and historically have had poor outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research